Jeffrey A. Gelfand
Corporate Officer/Principal en Brighton Biotech, Inc. .
Perfil
Jeffrey A.
Gelfand is currently a Scientific Advisor at Brighton Biotech, Inc. He was previously an Advisor at Maxwell Asset Management LLC (US).
Cargos activos de Jeffrey A. Gelfand
| Empresas | Cargo | Inicio |
|---|---|---|
Brighton Biotech, Inc.
 Brighton Biotech, Inc. BiotechnologyHealth Technology Brighton Biotech, Inc. provides medical research services. It specializes in acquiring and developing pharmaceutical and biotechnology products intended for the treatment and prevention of serious unmet medical needs. The company was founded in 2010 and is headquartered in New York, NY. | Corporate Officer/Principal | - |
Antiguos cargos conocidos de Jeffrey A. Gelfand.
| Empresas | Cargo | Fin |
|---|---|---|
Maxwell Asset Management LLC (US)
 Maxwell Asset Management LLC (US) Investment ManagersFinance Founded in 2003, Maxwell Asset Management LLC is a venture capital firm located in Boston. The firm is a subsidiary of Moscow-based Maxwell Capital Group LLC. They manage the Maxwell Biotech Venture Fund, Russia's first venture fund focused on the medical and biotechnology sectors. The fund is one of the first venture funds formed with the participation of the Russian Venture Company (RVC), a fund-of-funds created by the Russian government to promote the development of the venture capital industry and an innovation-based economy. | Corporate Officer/Principal | - |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas privadas | 2 |
|---|---|
Maxwell Asset Management LLC (US)
Maxwell Asset Management LLC (US) Investment ManagersFinance Founded in 2003, Maxwell Asset Management LLC is a venture capital firm located in Boston. The firm is a subsidiary of Moscow-based Maxwell Capital Group LLC. They manage the Maxwell Biotech Venture Fund, Russia's first venture fund focused on the medical and biotechnology sectors. The fund is one of the first venture funds formed with the participation of the Russian Venture Company (RVC), a fund-of-funds created by the Russian government to promote the development of the venture capital industry and an innovation-based economy. | Finance |
Brighton Biotech, Inc.
Brighton Biotech, Inc. BiotechnologyHealth Technology Brighton Biotech, Inc. provides medical research services. It specializes in acquiring and developing pharmaceutical and biotechnology products intended for the treatment and prevention of serious unmet medical needs. The company was founded in 2010 and is headquartered in New York, NY. | Health Technology |
- Bolsa de valores
- Insiders
- Jeffrey A. Gelfand
